Scarica l'app Stockscreener
61.44
3.17%
1.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$59.58
Aprire:
$59.62
Volume 24 ore:
1.38M
Relative Volume:
0.58
Capitalizzazione di mercato:
$9.57B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
65.36
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
+2.62%
1M Prestazione:
+18.71%
6M Prestazione:
+23.00%
1 anno Prestazione:
-14.39%
Intervallo 1D:
$59.61
$62.37
Intervallo di 1 settimana:
$57.85
$62.37
Portata 52W:
$46.01
$80.80
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
61.47 | 9.23B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.46 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.96 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.68 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
831.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.38 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Visual analytics tools that track Bio Techne Corporation performancePortfolio Value Report & Stepwise Trade Execution Plans - newser.com
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents - Yahoo Finance
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results - Yahoo Finance
Bio-Techne (TECH) Analyst Rating Update: TD Cowen Raises Price T - GuruFocus
Earnings Preview: What to Expect From Bio-Techne's Report - MSN
Earnings Preview: What To Expect From Bio-Techne's Report - Barchart.com
Will Bio Techne Corporation price bounce be sustainableEntry Point & AI Forecasted Entry/Exit Points - newser.com
Smart tools for monitoring Bio Techne Corporation’s price actionMarket Movement Recap & Community Supported Trade Ideas - newser.com
Is Bio Techne Corporation stock a contrarian buy2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
KLP Kapitalforvaltning AS Decreases Stake in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Investor Outlook: Navigating Growth with a 13.65% Potential Upside - DirectorsTalk Interviews
Statistical indicators supporting Bio Techne Corporation’s strengthJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Legal Advantage Investments Inc. Acquires 5,000 Shares of Bio-Techne Corp $TECH - MarketBeat
ConMed adds Bio-Techne CEO to board of directors - Central New York Business Journal
Bio-Techne (TECH): Valuation Spotlight Following Expanded Oxford Nanopore Partnership and Growth Strategy Realignment - Yahoo Finance
Bio Techne Corporation stock daily chart insightsEarnings Growth Report & Smart Investment Allocation Insights - newser.com
Can Bio Techne Corporation recover in the next quarterWeekly Stock Summary & Verified Momentum Stock Alerts - newser.com
Will Bio Techne Corporation stock deliver shareholder valueJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 - Investing News Network
Bio-Techne (TECH) Expands Partnership with Oxford Nanopore Technologies - GuruFocus
Bio-techne expands genetic testing collaboration with Oxford Nanopore - Investing.com
Bio-techne expands genetic testing collaboration with Oxford Nanopore By Investing.com - Investing.com South Africa
Is Bio Techne Corporation (TE1) stock resilient in recession scenariosTrade Entry Report & Reliable Price Action Trade Plans - newser.com
Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - sharewise.com
Citi Sticks to Their Buy Rating for Bio-Techne (TECH) - The Globe and Mail
Bio-Techne (TECH) Receives a Buy from Evercore ISI - The Globe and Mail
Evercore ISI Group Raises Bio-Techne (TECH) Price Target to $72 | TECH Stock News - GuruFocus
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Citi Maintains Bio-Techne(TECH.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛
How Bio Techne Corporation stock performs in rate cut cyclesTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
20,000 Shares in Bio-Techne Corp $TECH Purchased by Hunter Perkins Capital Management LLC - MarketBeat
Will Bio-Techne's (TECH) Latest Spatial Biology Tools Reshape Its Edge in Translational Research? - simplywall.st
Bio-Techne (TECH) Surges Over 21% as Healthcare Stocks Rally - GuruFocus
Bio Techne Corporation stock volume spike explained2025 Trade Ideas & Daily Profit Focused Stock Screening - newser.com
Bio-Techne Corp. Hits Day High with 10.2% Surge in Strong Intraday Performance - Markets Mojo
Bio-Techne (TECH): Assessing the Valuation as Shares Continue Their Recent Upward Momentum - simplywall.st
Why Bio Techne Corporation (TE1) stock trades below fair value2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Can Bio Techne Corporation (TE1) stock beat analyst consensusWeekly Market Report & Low Risk Entry Point Guides - newser.com
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know - The Globe and Mail
Could Spatial Biology Advances Shape Bio-Techne's (TECH) Long-Term Position in Precision Medicine? - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MSN
The Best Biotech Stocks to Buy - Morningstar
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - Yahoo Finance
Bio-Techne (TECH) Shares Skyrocket, What You Need To Know - Yahoo Finance
What analysts say about Bio Techne Corporation TE1 stockIPO Market Watch & Free Discover Dynamic Stocks - earlytimes.in
Bio-Techne (NASDAQ:TECH) Trading Up 4.7%What's Next? - MarketBeat
Is Bio Techne Corporation (TE1) stock positioned for secular growthDollar Strength & Real-Time Buy Signal Alerts - newser.com
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions - The Globe and Mail
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
4.86%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):